Skip to main content
Shinnyi Chou on Muck Rack

Shinnyi Chou

As seen in: BioRxiv, Biological Psychiatry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shinnyi

Contact Shinnyi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Terminal Type-Specific Cannabinoid CB1 Receptor Alterations in Patients With Schizophrenia

|
By Shinnyi Chou
| Biological Psychiatry Verified
Individuals with schizophrenia use cannabis at a higher rate than the general population and may experience disease symptom exacerbations when exposed to cannabis. The major psychoactive substance in cannabis delta-9-tetrahydrocannabinol, targets the cannabinoid CB1 receptor (CB1R). Thus far, studies examining CB1R alterations in schizophrenia have led to conflicting results.
Open in Who Shared Issue with article?

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study

|
By Kenneth N. Fish, David Lewis, Robert Sweet, Shinnyi Chou
| BioRxiv
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Open in Who Shared Issue with article?
See all 2 articles